Patents by Inventor Kristin Stanford

Kristin Stanford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions relating to lipokines for treating metabolic disorders
    Patent number: 12005039
    Abstract: The invention includes methods and compositions for treating a metabolic disorder, such as metabolic syndrome, hyperlipidemia and associated disorders, such as obesity and diabetes. The invention includes a method of treating a human subject comprising administering 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) to the subject. The invention also includes methods and compositions for treating disorders and conditions that would benefit from skeletal muscle fatty acid uptake and oxidation, increased mitochondrial respiration in skeletal muscle and/or enhanced exercise capacity.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: June 11, 2024
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Laurie J. Goodyear, Kristin Stanford
  • METHODS TO CONTROL LIPOKINE CONCENTRATIONS AND USES THEREOF
    Publication number: 20230279372
    Abstract: The present disclosure relates to compositions for regulating lipokines and methods of use thereof.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 7, 2023
    Inventors: Kristin STANFORD, Daniel GALLEGO PEREZ, Mark ZIOLO
  • METHODS AND COMPOSITIONS RELATING TO LIPOKINES FOR TREATING METABOLIC DISORDERS
    Publication number: 20210161848
    Abstract: The invention includes methods and compositions for treating a metabolic disorder, such as metabolic syndrome, hyperlipidemia and associated disorders, such as obesity and diabetes. The invention includes a method of treating a human subject comprising administering 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) to the subject. The invention also includes methods and compositions for treating disorders and conditions that would benefit from skeletal muscle fatty acid uptake and oxidation, increased mitochondrial respiration in skeletal muscle and/or enhanced exercise capacity.
    Type: Application
    Filed: October 26, 2020
    Publication date: June 3, 2021
    Inventors: Laurie J. Goodyear, Kristin Stanford